Next, we verified whether the key mechanism by which COPD aggravates AS is pulmonary microvascular barrier dysfunction through in vitro experiments and whether TXL can protect the function of the pulmonary microvascular barrier. This evidence concerns the gene TXNL1 and chronic obstructive pulmonary disease.